Treatment of Cytomegalovirus Infection
Cytomegalovirus (CMV) infection is a highly prevalent condition today, significantly impacting daily work and quality of life. What are the treatment options for CMV infection?
Treatment Options for Cytomegalovirus Infection
CMV infection is widespread in the general population. While only a small proportion of infected individuals exhibit clinical symptoms, most remain in a state of asymptomatic (latent) infection—symptoms typically emerge only when immune function is compromised. CMV is the most common cause of congenital viral infection in humans and can lead to a spectrum of infection-related syndromes in newborns. Therefore, women planning pregnancy and immunocompromised individuals should undergo timely screening and initiate prompt treatment upon diagnosis. Antiviral therapy commonly includes ganciclovir, which is the first-line agent for treating human CMV infection.

CMV infection refers to either congenital or acquired infection caused by cytomegalovirus. Clinical manifestations and outcomes following CMV infection are closely associated with the host’s immune status. In immunocompetent individuals, CMV infection typically occurs through close contact with infectious bodily secretions from an infected person.

In immunocompromised patients, primary CMV infection or reactivation of latent CMV—often triggered by blood transfusion or organ transplantation—can involve single or multiple organs. The most common manifestations include interstitial pneumonia, hepatitis, gastroenteritis, and retinitis. We hope this information proves helpful to you.